Ellsworth Advisors LLC purchased a new stake in shares of Globe Life Inc. (NYSE:GL - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 33,954 shares of the company's stock, valued at approximately $4,472,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Amalgamated Bank grew its holdings in shares of Globe Life by 0.5% in the first quarter. Amalgamated Bank now owns 16,348 shares of the company's stock worth $2,153,000 after purchasing an additional 85 shares during the last quarter. Pinnacle Wealth Planning Services Inc. increased its stake in shares of Globe Life by 4.0% in the fourth quarter. Pinnacle Wealth Planning Services Inc. now owns 2,293 shares of the company's stock worth $256,000 after buying an additional 88 shares during the period. Envestnet Portfolio Solutions Inc. increased its stake in shares of Globe Life by 0.5% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 19,776 shares of the company's stock worth $2,605,000 after buying an additional 89 shares during the period. Venturi Wealth Management LLC increased its stake in shares of Globe Life by 1.1% in the first quarter. Venturi Wealth Management LLC now owns 8,226 shares of the company's stock worth $1,084,000 after buying an additional 93 shares during the period. Finally, HighPoint Advisor Group LLC increased its stake in shares of Globe Life by 4.2% in the first quarter. HighPoint Advisor Group LLC now owns 2,366 shares of the company's stock worth $293,000 after buying an additional 95 shares during the period. 81.61% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Globe Life
In other news, EVP Michael Clay Majors sold 10,000 shares of the business's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the sale, the executive vice president owned 47,066 shares in the company, valued at approximately $6,467,339.06. The trade was a 17.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO James Matthew Darden sold 33,270 shares of the business's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the sale, the chief executive officer owned 49,842 shares in the company, valued at approximately $6,758,076.78. This trade represents a 40.03% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 84,722 shares of company stock worth $11,733,793. Corporate insiders own 1.51% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages recently commented on GL. Wall Street Zen raised shares of Globe Life from a "hold" rating to a "buy" rating in a research note on Friday, May 16th. BMO Capital Markets reaffirmed a "market perform" rating and issued a $149.00 target price (up from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Morgan Stanley lifted their target price on shares of Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a research note on Monday, August 18th. Finally, Cfra Research raised shares of Globe Life to a "moderate buy" rating in a research note on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $152.45.
Read Our Latest Analysis on Globe Life
Globe Life Trading Down 0.2%
NYSE:GL traded down $0.24 during trading hours on Friday, hitting $142.25. The company had a trading volume of 400,575 shares, compared to its average volume of 440,235. The company has a market capitalization of $11.52 billion, a PE ratio of 11.37 and a beta of 0.56. The stock has a 50-day moving average price of $134.42 and a 200 day moving average price of $126.74. Globe Life Inc. has a 52 week low of $100.27 and a 52 week high of $144.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06.
Globe Life (NYSE:GL - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The firm had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the previous year, the business posted $2.97 EPS. The company's quarterly revenue was up 2.9% on a year-over-year basis. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, equities research analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, October 3rd. Globe Life's payout ratio is 8.63%.
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Read More

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.